Genetic Loss of LCK Kinase Leads to Acceleration of Chronic Lymphocytic Leukemia

Most patients with chronic lymphocytic leukemia (CLL) exhibit an indolent disease course and unresponsive B cell receptors (BCRs) exemplified by an anergic phenotype of their leukemic cells. In up to 5% of patients, CLL transforms from an indolent subtype to an aggressive form of B cell lymphoma (Ri...

Descripción completa

Detalles Bibliográficos
Autores principales: Märklin, Melanie, Fuchs, Alexander R., Tandler, Claudia, Heitmann, Jonas S., Salih, Helmut R., Kauer, Joseph, Quintanilla-Martinez, Leticia, Wirths, Stefan, Kopp, Hans-Georg, Müller, Martin R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7492521/
https://www.ncbi.nlm.nih.gov/pubmed/32983140
http://dx.doi.org/10.3389/fimmu.2020.01995

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7492521/
https://www.ncbi.nlm.nih.gov/pubmed/32983140
http://dx.doi.org/10.3389/fimmu.2020.01995

Ejemplares similares